Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper
Sublingual immunotherapy (SLIT) is a matter of only 20 years. Nonetheless, in this short period of time more than 60 randomized double blind placebo-controlled trials have been published, in addition to postmarketing surveillance studies and meta-analyses. The wide diffusion of SLIT in clinical prac...
Main Authors: | Giovanni. Passalacqua, MD, Enrico. Compalati, MD, Giorgio Walter Canonica, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119304818 |
Similar Items
-
Sublingual Immunotherapy: Recent Advances
by: Enrico Compalati, et al.
Published: (2013-01-01) -
Is Sublingual Immunotherapy the Final Answer? Implications for the Allergist
by: Giorgio Walter Canonica, MD, et al.
Published: (2008-01-01) -
Sublingual immunotherapy (SLIT) – indications, mechanism, and efficacy
Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy
by: Marek Jutel, et al.
Published: (2015-12-01) -
Sublingual immunotherapy: World Allergy Organization position paper 2013 update
by: Giorgio Walter Canonica, et al.
Published: (2014-01-01) -
Allergen immunotherapy on the way to product-based evaluation—a WAO statement
by: Claus Bachert, et al.
Published: (2015-01-01)